© Copyright 2025 American Medical Association. All rights reserved.
Short Descr | ADM SARSCOV2 5MCG/0.5ML 2ND | Medium Descr | IMM ADMN SARSCOV2 5 MCG/0.5 ML 2ND DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; second dose | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
Date
|
Action
|
Notes
|
---|---|---|
2025-01-01 | Deleted | First appearance of code deletion in codebook. |
2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
2022-10-19 | Note | AMA guideline changed. 0044A received FDA approval |
2022-10-10 | Note | AMA guideline changed to include 0044A effective upon receiving Emergency Use Authorization or approval from the FDA |
2022-10-10 | Note | Changes made to include 12 years and older. |
2022-08-31 | Note | Changes made to vaccine patient age (18+). |
2022-07-13 | Added | Received FDA Approval |
2022-07-13 | Note | AMA guideline changed. FDA approval received for 91304. Approval published to website 2022-07-26. FDA approval effective retroactively to 2022-07-13. |
2022-07-13 | Note | AMA Guideline changed. 0041A received FDA approval. |
2022-01-01 | Added | First appearance in codebook. |
2022-01-01 | Note | Grammar correction |
2022-01-01 | Changed | Code description changed. |
2021-05-04 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |
2021-05-04 | Note | AMA guideline added to include 0041A, 91304; Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the FDA. |